These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 6582586
1. Treatment of advanced bone marrow neoplasms with ifosfamide combinations. Norberg B, Holm J, Winqvist E, Wahlin A. Scand J Haematol; 1984 Jan; 32(1):95-100. PubMed ID: 6582586 [Abstract] [Full Text] [Related]
2. Relapse of adult acute lymphoblastic leukaemia treated with ifosfamide combination chemotherapy. Timonen TT. Cancer Treat Rev; 1983 Sep; 10 Suppl A():145-50. PubMed ID: 6578874 [No Abstract] [Full Text] [Related]
3. Corticosteroid drugs: their role in oncological practice. Lowenthal RM, Jestrimski KW. Med J Aust; 1986 Jan 20; 144(2):81-5. PubMed ID: 2417096 [No Abstract] [Full Text] [Related]
4. Randomised trial comparing sequential methotrexate (or 5-FU), vinblastine and ifosfamide to vincristine, adriamycin and ifosfamide in advanced lung cancer. Focan C, Le Hung S, Bays-Gallaix R, Frere MH, Demonceau G, Mbuyamba P, Claessens JJ. Cancer Treat Rev; 1983 Sep 20; 10 Suppl A():103-10. PubMed ID: 6354441 [Abstract] [Full Text] [Related]
5. Cytokinetic studies in acute leukemia during early induction therapy. Traversi E, Riccardi A, Montecucco C, Mazzini G, Giordano P. Tumori; 1985 Feb 28; 71(1):69-74. PubMed ID: 3856963 [Abstract] [Full Text] [Related]
6. Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease. Brosteanu O, Hasenclever D, Loeffler M, Diehl V, German Hodgkin's Lymphoma Study Group. Ann Hematol; 2004 Mar 28; 83(3):176-82. PubMed ID: 15064867 [Abstract] [Full Text] [Related]
8. [Richter's syndrome (reversible after chemotherapy) during chronic lymphatic leukemia. Brief description of a case]. Cartei G, Fusaro A, Fornasiero A, Poletti A. G Clin Med; 1983 Mar 28; 64(7-8):252-6. PubMed ID: 6688996 [No Abstract] [Full Text] [Related]
9. Vincristine, prednisone, and daunomycin in acute leukemia of childhood. Vietti TJ, Starling K, Wilbur JR, Lonsdale D, Lane DM. Cancer; 1971 Mar 28; 27(3):602-7. PubMed ID: 5279331 [No Abstract] [Full Text] [Related]
10. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol. Pileri A, Barbui T, Boccadoro M, Comotti B, Dammacco F, Gallamini A, Marmont F, Neretto G, Petrucci MT, Resegotti L. Bone Marrow Transplant; 1989 Jan 28; 4 Suppl 1():168-9. PubMed ID: 2713554 [No Abstract] [Full Text] [Related]
11. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E. Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727 [Abstract] [Full Text] [Related]
12. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)]. Robak T, Krykowski E, Płuzańska A, Olszańska-Skorek T, Urbańska-Ryś H, Polkowska-Kulesza E, Błasińska-Morawiec M, Mazurowa A. Pol Tyg Lek; 1983 Apr 18; 38(16):481-4. PubMed ID: 6579509 [No Abstract] [Full Text] [Related]
13. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS. Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446 [Abstract] [Full Text] [Related]
14. Regression of HTLV1 associated intracardiac lymphoma following chemotherapy. Hamaad A, Davis RC, Connolly DL. Heart; 2002 Dec 15; 88(6):621. PubMed ID: 12433893 [No Abstract] [Full Text] [Related]
15. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma. Thomson B, Hawkins D, Felgenhauer J, Radich J. Bone Marrow Transplant; 1999 Sep 15; 24(5):527-33. PubMed ID: 10482938 [Abstract] [Full Text] [Related]
16. [Chimiotherapy of cancers (operational research of its efficiency and its place in therapeutic strategy of neoplasic diseases)]. Mathé G. Presse Med (1893); 1969 Mar 01; 77(11):383-4. PubMed ID: 5254392 [No Abstract] [Full Text] [Related]
17. Anaplastic myeloma. Zervas K, Constantinou N, Karakantza M, Tsigalidou-Balla V. Leuk Lymphoma; 1995 Feb 01; 16(5-6):515-8. PubMed ID: 7787758 [Abstract] [Full Text] [Related]
18. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Paciucci PA, Cuttner J, Holland JF. Semin Oncol; 1984 Sep 01; 11(3 Suppl 1):36-40. PubMed ID: 6385264 [Abstract] [Full Text] [Related]
19. [Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report]. Kehl A, Bergholz M, von Heyden HW, Nagel GA. Onkologie; 1983 Apr 01; 6(2):84-6. PubMed ID: 6306532 [No Abstract] [Full Text] [Related]